Cargando…

Lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes

INTRODUCTION: Patients with type 1 diabetes has an increased risk of fracture. We wished to evaluate estimated bone strength in children and adolescents with type 1 diabetes and assess peripheral bone geometry, volumetric bone mineral density (vBMD) and microarchitecture. RESEARCH DESIGN AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuusager, Gitte, Milandt, Nikolaj, Shanbhogue, Vikram Vinod, Hermann, Anne Pernille, Schou, Anders Jørgen, Christesen, Henrik Thybo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437694/
https://www.ncbi.nlm.nih.gov/pubmed/32816873
http://dx.doi.org/10.1136/bmjdrc-2020-001384
_version_ 1783572669532209152
author Fuusager, Gitte
Milandt, Nikolaj
Shanbhogue, Vikram Vinod
Hermann, Anne Pernille
Schou, Anders Jørgen
Christesen, Henrik Thybo
author_facet Fuusager, Gitte
Milandt, Nikolaj
Shanbhogue, Vikram Vinod
Hermann, Anne Pernille
Schou, Anders Jørgen
Christesen, Henrik Thybo
author_sort Fuusager, Gitte
collection PubMed
description INTRODUCTION: Patients with type 1 diabetes has an increased risk of fracture. We wished to evaluate estimated bone strength in children and adolescents with type 1 diabetes and assess peripheral bone geometry, volumetric bone mineral density (vBMD) and microarchitecture. RESEARCH DESIGN AND METHODS: In a cross-sectional study, high-resolution peripheral quantitative CT (HR-pQCT) was performed of the radius and tibia in 84 children with type 1 diabetes and 55 healthy sibling controls. Estimated bone strength was assessed using a microfinite element analysis solver. Multivariate regression analyses were performed adjusting for age, sex, height and body mass index. RESULTS: The median age was 13.0 years in the diabetes group vs 11.5 years in healthy sibling controls. The median (range) diabetes duration was 4.2 (0.4−15.9) years; median (range) latest year Hb1Ac was 7.8 (5.9−11.8) % (61.8 (41−106) mmol/mol). In adjusted analyses, patients with type 1 diabetes had reduced estimated bone strength in both radius, β −390.6 (−621.2 to −159.9) N, p=0.001, and tibia, β −891.9 (−1321 to −462.9) N, p<0.001. In the radius and tibia, children with type 1 diabetes had reduced cortical area, trabecular vBMD, trabecular number and trabecular bone volume fraction and increased trabecular inhomogeneity, adjusted p<0.05 for all. Latest year HbA1c was negatively correlated with bone microarchitecture (radius and tibia), trabecular vBMD and estimated bone strength (tibia). CONCLUSION: Children with type 1 diabetes had reduced estimated bone strength. This reduced bone strength could partly be explained by reduced trabecular bone mineral density, adverse microarchitecture and reduced cortical area. We also found increasing latest year HbA1c to be associated with several adverse changes in bone parameters. HR-pQCT holds potential to identify early adverse bone changes and to explain the increased fracture risk in young patients with type 1 diabetes.
format Online
Article
Text
id pubmed-7437694
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-74376942020-08-24 Lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes Fuusager, Gitte Milandt, Nikolaj Shanbhogue, Vikram Vinod Hermann, Anne Pernille Schou, Anders Jørgen Christesen, Henrik Thybo BMJ Open Diabetes Res Care Pathophysiology/Complications INTRODUCTION: Patients with type 1 diabetes has an increased risk of fracture. We wished to evaluate estimated bone strength in children and adolescents with type 1 diabetes and assess peripheral bone geometry, volumetric bone mineral density (vBMD) and microarchitecture. RESEARCH DESIGN AND METHODS: In a cross-sectional study, high-resolution peripheral quantitative CT (HR-pQCT) was performed of the radius and tibia in 84 children with type 1 diabetes and 55 healthy sibling controls. Estimated bone strength was assessed using a microfinite element analysis solver. Multivariate regression analyses were performed adjusting for age, sex, height and body mass index. RESULTS: The median age was 13.0 years in the diabetes group vs 11.5 years in healthy sibling controls. The median (range) diabetes duration was 4.2 (0.4−15.9) years; median (range) latest year Hb1Ac was 7.8 (5.9−11.8) % (61.8 (41−106) mmol/mol). In adjusted analyses, patients with type 1 diabetes had reduced estimated bone strength in both radius, β −390.6 (−621.2 to −159.9) N, p=0.001, and tibia, β −891.9 (−1321 to −462.9) N, p<0.001. In the radius and tibia, children with type 1 diabetes had reduced cortical area, trabecular vBMD, trabecular number and trabecular bone volume fraction and increased trabecular inhomogeneity, adjusted p<0.05 for all. Latest year HbA1c was negatively correlated with bone microarchitecture (radius and tibia), trabecular vBMD and estimated bone strength (tibia). CONCLUSION: Children with type 1 diabetes had reduced estimated bone strength. This reduced bone strength could partly be explained by reduced trabecular bone mineral density, adverse microarchitecture and reduced cortical area. We also found increasing latest year HbA1c to be associated with several adverse changes in bone parameters. HR-pQCT holds potential to identify early adverse bone changes and to explain the increased fracture risk in young patients with type 1 diabetes. BMJ Publishing Group 2020-08-17 /pmc/articles/PMC7437694/ /pubmed/32816873 http://dx.doi.org/10.1136/bmjdrc-2020-001384 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Pathophysiology/Complications
Fuusager, Gitte
Milandt, Nikolaj
Shanbhogue, Vikram Vinod
Hermann, Anne Pernille
Schou, Anders Jørgen
Christesen, Henrik Thybo
Lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes
title Lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes
title_full Lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes
title_fullStr Lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes
title_full_unstemmed Lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes
title_short Lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes
title_sort lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes
topic Pathophysiology/Complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437694/
https://www.ncbi.nlm.nih.gov/pubmed/32816873
http://dx.doi.org/10.1136/bmjdrc-2020-001384
work_keys_str_mv AT fuusagergitte lowerestimatedbonestrengthandimpairedbonemicroarchitectureinchildrenwithtype1diabetes
AT milandtnikolaj lowerestimatedbonestrengthandimpairedbonemicroarchitectureinchildrenwithtype1diabetes
AT shanbhoguevikramvinod lowerestimatedbonestrengthandimpairedbonemicroarchitectureinchildrenwithtype1diabetes
AT hermannannepernille lowerestimatedbonestrengthandimpairedbonemicroarchitectureinchildrenwithtype1diabetes
AT schouandersjørgen lowerestimatedbonestrengthandimpairedbonemicroarchitectureinchildrenwithtype1diabetes
AT christesenhenrikthybo lowerestimatedbonestrengthandimpairedbonemicroarchitectureinchildrenwithtype1diabetes